元徵科技(02488.HK)2021年淨利潤為9100萬元 同比增長約178%
格隆匯3月31日丨元徵科技(02488.HK)發佈公吿,2021年度,公司銷售收入13.45億元,較去年同期增長26%。其中診斷設備軟件分部收入較去年同期增長25%至11.36億元,佔集團銷售收入84.5%;維修設備分部收入較去年同期增長45%至6000萬元,佔集團銷售收入4.5%;海外分部收入較去年同期增長27%至1.49億元,佔集團銷售收入11%,各分部收入佔比分佈與去年相若。
綜合毛利率下跌約5個百分點至約40%,主要由於全球半導體短缺,航運價格高企,包括芯片在內的原材料大幅上漲,導致成本上升所致。集團歸屬於母公司所有者的淨利潤為9100萬元,較去年同期增長約178%。淨利大幅增加主要是由於毛利增加及費用大幅減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.